Control Group Quarterly Report – 2nd Edition – April 2024

ABSTRACT

In this, the second edition of the Control Group Quarterly Report, our analytics team build upon the foundations laid down in the first report (released in January 2024), and take at deeper look at our COVID-related data, including the use and reliability of COVID tests, the severity of disease in those who report having COVID, and our data around ‘Long COVID’.

We also reveal the number of COVID-vaccinated contributing to the Control Group database, the percentage of these participants who report having vaccine injuries, how many vaccines were taken before side-effects occurred, and what side effects are being reported.

We take a speculative glance at shedding, and some of the problems involved in reporting upon the phenomenon. And we also survey the present data we have on the prevalence of cancer, examining the most common types of cancer people in the Control Group survey report having, at what stage they received a diagnosis, and whether or not their condition has been resolved.

Insights include:

• Participation Demographics
• COVID testing
• COVID vaccinations
• COVID vaccination injuries
• Long COVID
• Shedding
• Cancer

This report has been inspired by the questions posed to our analytics team by participants in the Control Group study through our ‘Direction of Control Group Research?’ questionnaire.

CLICK HERE TO VIEW AND DOWNLOAD THE REPORT

Reference for this paper:

Fielder, D., van Kleeff, D., et al., The Quarterly Report, ed. 2, Control Group, (April 2024).

PLEASE UPDATE YOUR RECORD TODAY

Login: https://prod.controlgroup.coop/account/login
Support: https://controlgroup.coop/support/index.html
Forgotten your password: Request a Magic Login Link

Our insights rely on you – thank you!